Please login or register first to view this content.
Oncology Resource Center
Drug Monographs
Click on the subsection below to see prescribing information
- Bladder, kidney, and other urologic cancers
- Bone and connective tissue cancer
- Breast cancer
- CNS cancer
- Colorectal and other GI cancers
- Cytoprotective and supportive care agents
- Eye cancer
- Gynecologic cancer
- Head and neck cancer
- Kaposi’s sarcoma
- Leukemias, lymphomas, and other hematologic cancers
- Melanoma and other skin cancers
- Pancreatic, thyroid, and other endocrine cancers
- Prostate and other male cancers
- Respiratory and thoracic cancers
NEWS & FEATURES
Rozlytrek, a Tumor Agnostic Therapy, Receives FDA Approval
FDA: Entacapone Not Associated With Increased Prostate Cancer Risk
FDA Warns of “Cure-All” Products That Actually Contain Bleach
USPSTF Reaffirms Recs Against Screening for Pancreatic Cancer
FDA Approves First Treatment for Tenosynovial Giant Cell Tumor
Trial Investigating Oncolytic Immunotherapy for Advanced Liver Cancer Discontinued
Bempegaldesleukin Combo Regimen Gets Breakthrough Status for Untreated Advanced Melanoma
FDA Approves Prostate Cancer Treatment Nubeqa
Keytruda Wins Approval for Advanced Esophageal Cancer
Certain Breast Implants, Tissue Expanders Recalled Due to Cancer Link
Keytruda Plus Lenvima Combo Gets Breakthrough Status for Hepatocellular Carcinoma
Imfinzi Labeling Updated With Overall Survival Data in NSCLC
Biosimilars Mvasi, Kanjinti Now Available in the US
BLA for Subcutaneous Formulation of Daratumumab Submitted to FDA
Imfinzi Receives Orphan Drug Designation for Small Cell Lung Cancer
Sugary Beverage Consumption Linked to Increased Cancer Risk
Isatuximab to Get FDA Review for Relapsed/Refractory Multiple Myeloma
WHO Updates List of Essential Medicines
